Prévalence de la co-infection par le virus de l’immunodéficience humaine et les virus de l’hépatite B et de l’hépatite C : étude multicentrique à Madagascar

Rakotozafindrabe, Andry Lalaina Rinà; Andriamifidison, R. N.; Rabenjanahary, Tovo Harimanana; Razafimahefa, Soloniaina Hélio; Rakotoarivelo, R.; Randria, Mamy Jean de Dieu; Ramanampamonjy, Rado Manitrala; Andrianasolo, Radonirina Lazasoa

doi:10.1007/s12157-016-0696-y

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concerning HIV-HCV co-infection the prevalence was similar to that was observed by Jean et al [2] (0%) in 2016 in Morocco. It was lower than those observed by Traoré [18] (0.1%) in 2014 in Mali; Ntagirabiri et al [15] (10.6%) in 2012 in Burundi; Kabinda et al [30] (10%) in 2010 in Congo; Rakotozafindrabe et al [31] (1.25%) in 2017 in Madagascar; Bosali et al [32] (0.7%) in 2012 in Congo, Yong Chan et al [26] (1.7%) in 2017 in Korea.…”

Section: Discussionmentioning

confidence: 54%

Frequency of hepatitis and HIV co-infection markers in blood donors at the Hospital Professor Bocar Sidy Sall of Kati-Mali

Sanou-Makan Konaté,

Kassoum Kayantao,

Seydou Simbo Diakité

et al. 2023

GSC Biol. Pharm. Sci.

View full text Add to dashboard Cite

The transmission of infectious agents such as human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) represents the greatest threat to the safety of blood transfusion to the recipient. The association of HIV infection with HBV and/or HCV is common worldwide, due to shared modes of transmission. The prevalence of HIV-HBV co-infection is estimated to be 5-10% in the United States and 20-30% in Asia and parts of sub-Saharan Africa. Other studies report HCV co-infection in 9-25% of HIV-infected patients. The aim of this study was to determine the frequency of markers of co-infection between hepatitis (B,C) and human immunodeficiency virus in blood donations collected at the CHU Kati blood transfusion center. It was a retrospective study conducted from October 1 to December 31, 2018. Data were collected from blood donors aged 18 to 60 years. The Pre-donation medical interview was the first barrier for the selection of subjects at risk. The sample was composed of 92% males and 8% females out of a total of 507 individuals sampled. Biological screening was performed by ELISA (Enzyme Linked Immuno Sorbent Assay). The results revealed a prevalence of 0.86% of HIV-HBV co-infection only in rhesus negative donors. No co-infection between HIV and HCV was found. This study showed that at the Kati University Hospital, only rhesus-negative donors presented cases of HIV-HBV co-infection.

show abstract